ADHD Clinical Trial
Official title:
Effect of Neurofeedback Intervention on the Development of ADHD in Children at Risk: a Comparative Study.
Forty children considered at risk for ADHD (subclinical ADHD) will be randomized to either a neurofeedback intervention or waiting list.
Attention Deficit Hyperactive Disorder (ADHD) is one of the most common mental disorders
among children. It is associated with an important burden to individuals, their families and
society. ADHD is a chronic condition and the majority of affected individuals presents
symptoms and associated functional deficit through adult life. Although pharmacological
treatment can be easily implemented and are short-term effective, its efficacy tends to
decrease with time and long-term effects are uncertain. Psychosocial treatments tend to be
effective only during treatment delivery and treatment effects are not sustained. New
treatment strategies are required in order to provide better care to ADHD patients. Early
interventions might avoid the development of the disorder, limit its persistency or prevent
associated deficits. The aim of this study is to evaluate the efficacy of a
non-pharmacological intervention for children at risk for ADHD.
This randomized controlled clinical trial has the aim of testing the efficacy of
neurofeedback for children at increased risk for ADHD (subclinical ADHD symptoms). This is
study is a multisite school based trial. Forty children from the 1st to the 4th grade with
subclinical ADHD symptoms will be randomized to neurofeedback or waiting list. Subclinical
ADHD will be defined as having 3-5 out of 9 inattention and/or hyperactivity/impulsivity
symptoms according to parents clinical evaluation (K-SADS-PL) but less than 6 symptoms
according to teachers report (assessed using SNAP-IV) OR 3-5 symptoms according to teachers
report and less than 6 according to parents clinical evaluation. Exclusion criteria includes
IQ lower than 80, severe mental disorder or neurological disease. Treatment will comprise 25
sessions of NF using Slow Cortical Potential training. Children will be invited to attend 2
sessions per week, each session comprises 4 blocs of 20 trials with both activation and
deactivation challenges. Eldith Tharaprax equipment will be used in both sites. The study,
including treatment sessions, will be conducted in schools. Two public schools were selected
to host the study, one in São Paulo and another in Porto Alegre, Brazil. Main outcome will
be parents rating scores for ADHD symptoms (SWAN questionnaire). To avoid bias due to the
low literacy of our population, parents will be assisted by a staff member to fill the SWANs
questionnaires. Second outcomes includes: 1) Performance on computerized tests designed to
measures time processing, basic processing, inhibitory control and executive function and
delay aversion and 2) Pre- post treatment differences on electrophysiological measures
(evoke related potentials during two tasks that requires sustained attention,
self-monitoring and response to attentional prime); 3) conversion to ADHD (incident cases).
Outcomes measures will be assessed prior to treatment start, in after the 13 session, soon
after the 25 session, after 6 months of follow-up. Random regression will be used to model
each subject's response against time (from baseline to session 12 and from 12th session to
treatment end). For continuous variables we will compare the average slope of the regression
line across the two groups to test whether the intervention is superior to waiting-list.
Proportion of new cases will be compared across groups using chi square test.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03148782 -
Brain Plasticity Underlying Acquisition of New Organizational Skills in Children-R61 Phase
|
N/A | |
Recruiting |
NCT06038942 -
Formal Versus Informal Mindfulness Among University Students With Self-reported ADHD, Nonsuicidal Self-injury, or Stress
|
N/A | |
Not yet recruiting |
NCT06456372 -
Digital Health Intervention for Children With ADHD
|
N/A | |
Completed |
NCT05518435 -
Managing Young People With ADHD in Primary Care Study
|
||
Active, not recruiting |
NCT04978792 -
Does Cultivating Self-compassion Improve Resilience to Criticism and Improve Mental Health in Adults With ADHD?
|
N/A | |
Completed |
NCT03216512 -
Effects of Noise Cancelling Headphones on Neurocognitive and Academic Outcomes in ADHD
|
N/A | |
Completed |
NCT02829528 -
Little Flower Yoga for Kids: Evaluation of a Yoga and Mindfulness Program for Children With Increased Levels of Emotion Dysregulation and Inattention
|
N/A | |
Not yet recruiting |
NCT02906501 -
Effect of Risperidone on Cognitive Functions in Adolescents With ADHD and Behavioral Disturbances
|
N/A | |
Completed |
NCT02900144 -
Modified Comprehensive Behavioral Intervention for Tics (M_CBIT)
|
N/A | |
Completed |
NCT02562469 -
ACTIVATE: A Computerized Training Program for Children With ADHD
|
N/A | |
Terminated |
NCT02271880 -
Improving Medication Adherence in ADHD Adolescents
|
N/A | |
Recruiting |
NCT02255565 -
Dose Response Effects of Quillivant XR in Children With ADHD and Autism: A Pilot Study
|
Phase 4 | |
Completed |
NCT02463396 -
Mindfulness Training in Adults With ADHD
|
N/A | |
Completed |
NCT01673594 -
Prevention of Stimulant-Induced Euphoria With an Opioid Receptor Antagonist
|
Phase 4 | |
Terminated |
NCT01733680 -
Amiloride Hydrochloride as an Effective Treatment for ADHD
|
Early Phase 1 | |
Completed |
NCT02300597 -
Internet-based Support for Young People With ADHD and Autism - a Controlled Study
|
N/A | |
Active, not recruiting |
NCT01137318 -
Combined Cognitive Remediation and Behavioral Intervention for Treatment of Attention-deficit/Hyperactivity Disorder (ADHD)
|
Phase 2 | |
Completed |
NCT01404273 -
Functional MRI of Relaxation Response Training in Adults With Attention-Deficit/Hyperactivity Disorder
|
N/A | |
Completed |
NCT00573859 -
The Reinforcing Mechanisms of Smoking in Adult ADHD
|
Phase 1/Phase 2 | |
Completed |
NCT00586157 -
Study of Medication Patch to Treat Children Ages 6-12 With ADHD
|
Phase 4 |